OTU deubiquitinases reveal mechanisms of linkage specificity and enable ubiquitin chain restriction analysis.

Mevissen TE, Hospenthal MK, Geurink PP, Elliott PR, Akutsu M, Arnaudo N, Ekkebus R, Kulathu Y, Wauer T, El Oualid F, Freund SM, Ovaa H, Komander D. · 2013

Read OTU deubiquitinases reveal mechanisms of linkage specificity and enable ubiquitin chain restriction analysis. by Mevissen TE, Hospenthal MK, Geurink PP, Elliott PR, Akutsu M, Arnaudo N, Ekkebus R, Kulathu Y, Wauer T, El Oualid F, Freund SM, Ovaa H, Komander D. (2013) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3705208.txt.

Introduction

Mevissen and colleagues systematically tested the human OTU family of deubiquitinases, enzymes that remove ubiquitin tags from proteins, asking how each one chooses which chain type to cut. Sixteen family members exist, most regulating cell signalling, but their preferences had never been compared comprehensively.

Tested against all eight linkage types, most OTU enzymes proved choosy, favouring one, two, or a defined subset of chains, including rarely studied atypical ones. Crystal structures and biochemistry revealed four distinct mechanisms behind that selectivity. The team also turned the enzymes into a tool, ubiquitin chain restriction analysis, which uses them like restriction enzymes to read the chain types attached to a protein.

Catalog record

CREATORMevissen TE, Hospenthal MK, Geurink PP, Elliott PR, Akutsu M, Arnaudo N, Ekkebus R, Kulathu Y, Wauer T, El Oualid F, Freund SM, Ovaa H, Komander D.
YEAR2013
COLLECTIONPAPERS
FORMATTXT
FILE SIZE79 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC3705208

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

OTU Deubiquitinases Reveal Mechanisms of Linkage Specificity and Enable Ubiquitin Chain Restriction Analysis By Tycho ET Mevissen, Manuela K Hospenthal, Paul P Geurink, Paul R Elliott, Masato Akutsu, Nadia Arnaudo, Reggy Ekkebus, Yogesh Kulathu, Tobias Wauer, Farid El Oualid, Stefan MV Freund, Huib Ovaa Published in: Cell DOI: 10.1016/j.cell.2013.05.046 ABSTRACT Summary Sixteen ovarian tumor (OTU) family deubiquitinases (DUBs) exist in humans, and most members regulate cell-signaling cascades. Several OTU DUBs were reported to be ubiquitin (Ub) chain linkage specific, but comprehensive analyses are missing, and the underlying mechanisms of linkage specificity are unclear. Using Ub chains of all eight linkage types, we reveal that most human OTU enzymes are linkage specific, preferring one, two, or a defined subset of linkage types, including unstudied atypical Ub chains. Biochemical analysis and five crystal structures of OTU DUBs with or without Ub substrates reveal four mechanisms of linkage specificity. Additional Ub-binding domains, the ubiquitinated sequence in the substrate, and defined S1’ and S2 Ub-binding sites on the OTU domain enable OTU DUBs to distinguish linkage types. We introduce Ub chain restriction analysis, in which OTU DUBs are used as restriction enzymes to reveal linkage type and the relative abundance of Ub chains on substrates. INTRODUCTION Protein ubiquitination is a posttranslational modification of mostly Lys residues that regulates many cellular processes, including protein degradation, intracellular trafficking, cell signaling, autophagy, transcription, translation, and the DNA damage response (Komander and Rape, 2012). This functional diversity is achieved by the ability of ubiquitin (Ub) to form topologically distinct signals. Proteins can be monoubiquitinated at one or multiple sites or polyubiquitinated by modification with Ub chains. Within Ub chains, linkages can be formed via seven Ub Lys residues or via the N-terminal Met1, generating homotypic (one linkage type per polymer) or heterotypic (multiple linkage types per polymer) Ub chains (Komander and Rape, 2012). Differently linked Ub polymers have distinct cellular functions. Lys48-linked Ub chains serve as a proteasomal degradation signal (Hershko and Ciechanover, 1998), whereas Lys63-linked chains are nondegradative and, for example, activate protein kinase cascades (Chen and Sun, 2009). Lys11 linkages constitute an alternative degradation signal used during cell-cycle progression (Wickliffe et al., 2011). Met1-linked chains cooperate with Lys63 linkages in NF-κB signaling (Iwai, 2011). For the remaining four Ub chain types (Lys6, Lys27, Lys29, and Lys33), cellular roles are elusive (Kulathu and Komander, 2012). Deubiquitinases (DUBs) remove Ub modifications and regulate virtually all Ub-dependent processes (Komander et al., 2009; Reyes-Turcu et al., 2009). Many of the ∼80 DUBs that are predicted to be active in human cells have been implicated in human diseases such as neurodegeneration, inflammation, infection, and cancer (Clague et al., 2012). The subfamily of ovarian tumor (OTU) DUBs have emerged as regulators of important signaling cascades. A20 (Hymowitz and Wertz, 2010), OTUD7B/Cezanne (Hu et al., 2013) and OTULIN (Keusekotten et al., 2013) regulate NF-κB signaling, OTUD5/DUBA regulates interferon signaling (Kayagaki et al., 2007), OTUD2/YOD1 and VCPIP regulate p97-mediated processes (Ernst et al., 2009; Wang et al., 2004), and OTUB1 is involved in the DNA damage response (Nakada et al., 2010). Because of the complexity of the Ub modification, DUBs must display various layers of specificity—they must distinguish not only between Ub and Ub-like modifications but also between the eight Ub linkage types. Moreover, chain topology and length may also affect DUB activity (Komander et al., 2009). The extent to which DUBs are linkage specific is not clear. Characterized Ub-specific protease (USP) family DUBs are not linkage specific (Faesen et al., 2011). In contrast, OTU family DUBs can be linkage specific. OTUB1 prefers Lys48 linkages (Edelmann et al., 2009; Wang et al., 2009), Cezanne prefers Lys11 linkages (Bremm et al., 2010), TRABID is Lys29 and Lys33 specific (Licchesi et al., 2012), and OTULIN is Met1 specific (Keusekotten et al., 2013). However, with the exception of TRABID and OTULIN, comprehensive analyses comparing all chain types have not been performed. Here, we provide a biochemical characterization of all 16 human OTU DUBs that contain a complete catalytic triad and analyze their cross-reactivity against Ub-like molecules, catalytic activity, and linkage specificity. Most OTU DUBs show intrinsic linkage specificity, preferring one or a small defined subset of Ub linkage types. Mechanistic and structural studies of three closely related, unstudied OTUs with distinct cleavage profiles revealed four mechanisms for achieving linkage specificity, namely (1) the use of additional Ub-binding domains (UBDs), (2) specific recognition of a ubiquitinated sequence, (3) the use of a conserved S1’ Ub-binding site on the OTU domain itself, and (4) the use of an S2 site enabling DUBs to bind longer chains in a linkage-specific manner. The linkage specificity in OTU DUBs can be exploited in Ub chain restriction analysis, whereby linkage-specific DUBs are used to identify the linkage type(s) on a ubiquitinated protein. RESULTS The Human OTU Enzymes In the human genome, OTU domains exist in at least 18 genes, 14 of which have been annotated as active DUBs (Komander et al., 2009). In addition to these, OTULIN/FAM105B (Keusekotten et al., 2013) and ALG13 (UniProt Q9NP73) have recently been described or annotated as additional OTU domains with a complete catalytic triad. FAM105A (UniProt Q9NUU6) contains an OTULIN-like OTU domain but lacks catalytic triad residues. HIN1L is a pseudogene (http://www.ncbi.nlm.nih.gov/gene/360227). Phylogenetic analysis delineates four subfamilies: the OTUB subfamily/Otubains (OTUB1 and OTUB2), the OTUD subfamily (OTUD1, OTUD2/YOD1, OTUD3, OTUD4, OTUD5/DUBA, OTUD6A, OTUD6B, ALG13, and HIN1L), the A20-like subfamily (A20, Cezanne, Cezanne2, TRABID, and VCPIP), and the OTULIN subfamily (OTULIN and FAM105A) (Figure 1A). The size of the catalytic domain distinguishes subfamilies—OTUD enzymes being the smallest (∼150 amino acids [aa]), and the OTUB/OTULIN (220–270 aa) and A20-like OTUs (300–350 aa) containing larger catalytic folds. Most human OTUs contain additional domains, including UBDs (Figure 1B). [Figure: Human OTU DUBs and Reactivity of Analyzed Constructs(A) Phylogenetic tree of human OTU domain DUBs. HIN1L (∗) is a pseudogene, and FAM105A (∗∗) is lacking active site residues.(B) Domain composition in human OTU DUBs (updated from Komander et al. [2009]).(C) Constructs analyzed in this study. Full-length proteins not used in this study are shown in gray.(D) Purified OTU proteins according to (C) resolved on a Coomassie-stained 4%–12% SDS-PAGE gradient gel. M, marker. Asterisks (∗) indicate purified constructs.(E) Reactivity of analyzed constructs against the suicide probe Ub propargylamide (Ub-PA, upper panel) and Cy5-labeled Ub-PA (lower panel). Asterisks (∗) indicate the modified form of the OTU DUB.See also Figure S1.] We cloned the 16 catalytic-triad-containing human OTU DUBs from plasmids, IMAGE clones, or human complementary DNA (cDNA) libraries and expressed and purified full-length (FL) and/or OTU domain-containing constructs in E. coli (Figures 1C and 1D). Most OTUs reacted quantitatively with Ub propargylamide (Ub-PA) (Ekkebus et al., 2013), indicating proper folding and a reactive catalytic Cys (Figure 1E, Figure S1A available online). OTUD5/DUBA required activation by phosphorylation in the OTU domain by recombinant CK2 to display reactivity (Huang et al., 2012). OTULIN did not react with Ub-PA because it requires activation by a proximal Ub for activity (Keusekotten et al., 2013). ALG13 did not react with Ub-PA, but it did react with haloalkyl probes, and A20 reacted very slowly and incompletely with all tested probes (Figures 1E, S1A, and S1B). [Figure: Reactivity of Human OTU DUBs with Probes Derived from Ub and Ub-like Modifiers, Related

Read the complete text